4/A: CEO Silvestro Amends OPRX Stock Disclosure

OptimizeRx CEO Stephen L. Silvestro filed an amended Form 4 to clarify a stock disposition related to tax withholding on restricted stock units.

Summary

• Stephen L. Silvestro, Chief Executive Officer of OptimizeRx Corp (OPRX), filed an amended Form 4 (Form 4/A).
• The amendment clarifies a disposition of 3,361 shares of OptimizeRx common stock on December 23, 2025.
• These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy Mr. Silvestro's tax withholding obligations.
• The transaction price for the disposed shares was $12.74 per share.
• Following this reported transaction, Mr. Silvestro directly beneficially owns 190,507 shares of OptimizeRx common stock.
• The Form 4/A specifically removes an inapplicable disclosure regarding a Rule 10b5-1 plan, confirming the disposition was solely for tax withholding purposes.

Sentiment

Score: 5

Explanation: Neutral. This is an administrative filing clarifying a routine tax-related stock transaction by an executive, with no impact on company operations or financial performance.

Future Outlook

NA

Management Comments

• The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.

Industry Context

NA

Stakeholder Impact

• Shareholders: Minimal to no direct impact, as this is a routine administrative filing clarifying an executive's stock transaction for tax purposes.

Key Dates

Recommendation

This filing is an administrative amendment to clarify a routine executive stock disposition for tax withholding purposes. It provides no new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation.

Keywords

OptimizeRx Corp, OPRX, Stephen L. Silvestro, Form 4/A, Beneficial Ownership, Stock Disposition, Tax Withholding, Restricted Stock Units, CEO